Journal Article

High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer

Huang, Yen-Lin, Hung, Jung-Tung, Yu, Alice L., Liao, Yu-Mei, Hsu, Ya-Ling, Liao, Guo-Shiou, Wu, Jen-Chien, Wang, Ya-Hui, Lin, Yu-Ju

2021

Overview

Background Existence of breast cancer stem cells (BCSCs) is implicated in disease relapse, metastasis, and resistance of treatment. β1,3-Galactosyltransferase 5 (B3GALT5) has been shown to be a pro-survival marker for BCSCs. However, little is known about the prognostic significance of B3GALT5 in breast cancer. Methods Paired tissues (tumor part and adjacent non-tumor part) from a cohort of 202 women with breast cancer were used to determine the expression levels of B3GALT5 mRNA by qRT-PCR. Kaplan–Meier and multivariable Cox proportional hazard models were used to assess survival differences in terms of relapse-free survival (RFS) and overall survival (OS). Both breast cancer cells and cancer stem cells (BCSCs) were used to see the in vitro effects of knockdown or overexpression of B3GALT5 on cell migration, invasion, and epithelial-to-mesenchymal transition (EMT). A patient-derived xenograft (PDX) model was used to see the in vivo effects of knockdown of B3GALT5 in BCSCs on tumor growth and metastasis. Results Higher expression of B3GALT5 in 202 breast cancer tissues, especially in adjacent non-tumor tissue, correlated with poor clinical outcomes including shorter OS and RFS in all patients, especially those with early stage breast cancer. In vitro studies showed B3GALT5 could enhance cell migration, invasion, mammosphere formation, and EMT. Of note, B3GALT5 upregulated the expression of β-catenin and EMT activator zinc finger E-box binding homeobox 1 (ZEB1) pathway in BCSCs. In vivo studies showed B3GALT5 expression in BCSCs is critical for not only tumor growth but also lymph node and lung metastasis in PDX mice. Conclusion Our results demonstrated the value of B3GALT5 as a prognostic marker of breast cancer, especially among the early stage patients, and its crucial roles in regulating EMT, cell migration, and stemness thereby promoting breast cancer progression.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Animals / B3GALT5 / Biomarkers, Tumor / Biomedical and Life Sciences / Biomedicine / Breast cancer / Breast Neoplasms - genetics / Breast Neoplasms - metabolism / Breast Neoplasms - mortality / Breast Neoplasms - pathology / Cancer / Cancer Research / Cell adhesion & migration / Cell Line, Tumor / Cell migration / Cell Movement / Clinical outcome / Clinical outcomes / Development and progression / Disease Models, Animal / Disease Progression / Disease resistance / EMT / Epithelial-Mesenchymal Transition - genetics / Female / Galactosyltransferases - genetics / Galactosyltransferases - metabolism / Gene Expression / Gene Expression Regulation, Neoplastic / Gene Knockdown Techniques / Homeobox / Humans / Kinases / Laboratory animals / Lung cancer / Lymph nodes / Medical prognosis / Mesenchyme / Metastases / Metastasis / Mice / mRNA / Neoplasm Metastasis / Oncology / Oncology, Experimental / Patient outcomes / Patients / Prognosis / Proportional Hazards Models / Research Article / RNA / RNA Interference / Statistical analysis / Stem cell transplantation / Stem cells / Surgical Oncology / Xenografts / Zinc finger proteins / β-Catenin